Praluent
R727-CL-1609
Approved small_molecule terminated
Quick answer
Praluent for Heterozygous Familial Hypercholesterolemia is a Approved program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Heterozygous Familial Hypercholesterolemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated